Physician profile
Joseph E Mobley
NPI 1669426987
$9,595.08
in general payments reported to CMS, 2019-2025
50 companies · $2,649 in 2025
The $2,649 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $880 · 2020: $127 · 2021: $333 · 2022: $913 · 2023: $2,379 · 2024: $2,313 · 2025: $2,649.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,034 · Travel and Lodging: $2,307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,034.20 |
| Travel and Lodging | $2,307.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,669.73 | 2019-2025 | Triclip, Pressurewire, Xience Skypoint |
| Ge Healthcare | $1,372.38 | 2023 | |
| Boston Scientific Corporation | $634.30 | 2019-2025 | Watchman Flx, General - Therapies |
| Heartflow, INC. | $625.15 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $621.81 | 2019-2025 | |
| Inari Medical, INC. | $543.63 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Atricure, INC. | $529.46 | 2021-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Philips North America LLC | $258.25 | 2023-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Cm9) Amb Mon & Diag Und, Ecc Solutions |
| Janssen Pharmaceuticals, INC | $228.59 | 2023-2024 | Xarelto |
| Pfizer INC. | $225.60 | 2019-2025 | |
| Cvrx, INC. | $220.46 | 2024-2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $206.34 | 2019-2025 | Lifevest |
| Biotronik INC. | $181.58 | 2019-2023 | Biomonitor |
| Abiomed | $181.43 | 2024-2025 | Impella |
| Merck Sharp & Dohme LLC | $172.12 | 2022-2025 | Verquvo |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $149.13 | 2024-2025 | Onpattro |
| E.R. Squibb & Sons, L.L.C. | $144.34 | 2022-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $141.60 | 2021-2025 | Linq II, Onyx Frontier |
| Amgen INC. | $105.70 | 2024-2025 | Repatha, Repatha |
| Olympus America INC. | $104.85 | 2025 | Itind System |
| Cms Imaging, INC. | $101.69 | 2021 | |
| Chiesi USA, INC. | $99.67 | 2021-2025 | Kengreal |
| Stryker Corporation | $95.66 | 2025 | Clottriever Bold Catheter |
| Actelion Pharmaceuticals US, INC. | $86.89 | 2022-2024 | Opsumit, Uptravi |
| Astrazeneca Pharmaceuticals Lp | $76.82 | 2019-2025 | Farxiga |
| Gilead Sciences, INC. | $73.31 | 2019 | |
| Cardiovascular Systems INC. | $67.94 | 2022 | |
| Bridgebio Pharma, INC. | $57.16 | 2025 | Attruby |
| Lexicon Pharmaceuticals, INC. | $56.73 | 2024 | |
| Daiichi Sankyo INC. | $54.84 | 2022-2024 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $51.13 | 2025 | |
| Intuitive Surgical, INC. | $48.73 | 2025 | |
| Irhythm Technologies, INC. | $46.78 | 2024 | Zio Monitor, Zio Xt Patch |
| Kiniksa Pharmaceuticals, Ltd. | $39.61 | 2023 | Arcalyst |
| Change Healthcare Technologies, LLC | $36.14 | 2020 | |
| Sanofi-Aventis U.S. LLC | $34.20 | 2023 | |
| Edwards Lifesciences Corporation | $31.21 | 2024-2025 | Sapien 3 Ultra Resilia |
| Nuwellis, INC. | $28.82 | 2020 | |
| Recor Medical INC | $24.93 | 2024 | Paradise Renal Denervation System |
| Scpharmaceuticals INC. | $19.58 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $16.85 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $16.58 | 2025 | Assure Wcd |
| Tactile Systems Technology INC | $15.45 | 2024 | Entre Plus, Flexitouch Plus |
| Impulse Dynamics (USA) INC. | $14.97 | 2023 | Optimizer |
| Novo Nordisk INC | $14.91 | 2025 | Wegovy |
| Cleerly, INC. | $14.41 | 2024 | Cleerly Ischemia, Cleerly Labs |
| Esperion Therapeutics, INC. | $13.89 | 2024 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.68 | 2025 | Jardiance |
| Cashflow Solutions, LLC | $13.23 | 2024 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Altathera Pharmaceuticals LLC | $12.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Mobley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.